InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,427.74
(
-0.73%
)
Post# of 7597
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

big bambino

Send PM Follow Ignore
Followers 13
Posts 1903
Boards Moderated 0
Alias Born 03/03/2011

big bambino

Re: None

Friday, 12/11/2020 10:33:14 AM

Friday, December 11, 2020 10:33:14 AM

Post# of 7597
Reuters 08:35 AM ET December 11, 2020

*GERON ANNOUNCES OPENING OF IMPACTMF PHASE 3 CLINICAL TRIAL IN REFRACTORY MYELOFIBROSIS. *GERON CORP- PLANS TO ENGAGE OVER 150 SITES TO PARTICIPATE IN IMPACTMF ACROSS NORTH AMERICA, SOUTH AMERICA, EUROPE AND ASIA. *GERON CORP- MAJORITY OF CLINICAL SITES IN IMPACTMF EXPECTED TO BE OPEN FOR SCREENING AND ENROLLMENT IN 2021.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent GERN News
More GERN News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!